(Q30240734)

PubMed publication ID

12 June 2017

1 reference

title

The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

1 reference

coronary artery disease

1 reference

Ghassan J Maghzal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

Roland Stocker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

Jihan Talib

1 reference

12 May 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

Nathaniel Teng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

Imran Rashid

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

Antony K Lau

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

publication date

25 November 2016

1 reference

PubMed publication ID

12 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

page(s)

51-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

12 May 2020

start time

25 November 2016

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Current role of myeloperoxidase in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Macrophage Phenotype and Function in Different Stages of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Ceruloplasmin is an endogenous inhibitor of myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: glycosylation is required for optimal enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

X-ray crystal structure of canine myeloperoxidase at 3 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Active site structure and catalytic mechanisms of human peroxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Mammalian heme peroxidases: from molecular mechanisms to health implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Redox properties of the couples compound I/compound II and compound II/native enzyme of human myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

The Acid Ionization Constant of HOCl from 5 to 35°

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Kinetics and mechanisms of the reaction of hypothiocyanous acid with 5-thio-2-nitrobenzoic acid and reduced glutathione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Reconciling the chemistry and biology of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Hypochlorite-induced oxidation of amino acids, peptides and proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Histamine chloramine reactivity with thiol compounds, ascorbate, and methionine and with intracellular glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Pathways for the decay of organic dichloramines and liberation of antimicrobial chloramine gases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Increased atherosclerosis in myeloperoxidase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Hypochlorous acid impairs endothelium-derived nitric oxide bioactivity through a superoxide-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Candidate biomarkers for the detection of coronary plaque destabilization and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Major lipids, apolipoproteins, and risk of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Cardioprotective functions of HDLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Dysfunctional HDL as a diagnostic and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

High-density lipoprotein function, dysfunction, and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase, modified lipoproteins, and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

L-arginine chlorination products inhibit endothelial nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Trans-vessel gradient of myeloperoxidase in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Diagnostic performance of high-sensitivity troponin T, myeloperoxidase, and pregnancy-associated plasma protein A assays for triage of patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Plasma myeloperoxidase concentration predicts the presence and severity of coronary disease in patients with chest pain and negative troponin-T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Prognostic value of myeloperoxidase in patients with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Development of an ELISA for myeloperoxidase on microplate: normal reference values and effect of temperature on specimen preparation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase concentrations in EDTA-plasma of healthy subjects are discordant with concentrations in heparin-plasma and serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Measuring chlorine bleach in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Reactions of aqueous chlorine in vitro in stomach fluid from the rat: chlorination of tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Plasmalogens: biosynthesis and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

{Omega}-oxidation of {alpha}-chlorinated fatty acids: identification of {alpha}-chlorinated dicarboxylic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Production of glutathione sulfonamide and dehydroglutathione from GSH by myeloperoxidase-derived oxidants and detection using a novel LC-MS/MS method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Measuring myeloperoxidase activity in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Detection of the halogenating activity of heme peroxidases in leukocytes by aminophenyl fluorescein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Assessment of myeloperoxidase activity by the conversion of hydroethidine to 2-chloroethidium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

HKOCl-2 series of green BODIPY-based fluorescent probes for hypochlorous acid detection and imaging in live cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

A prospective natural-history study of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Clinical classification of plaque morphology in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Detection of lipid hydroperoxides and hydrogen peroxide at picomole levels by an HPLC and isoluminol chemiluminescence assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Bioluminescence imaging of myeloperoxidase activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Development of an Si-rhodamine-based far-red to near-infrared fluorescence probe selective for hypochlorous acid and its applications for biological imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Role of oxidative modifications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Plasma myeloperoxidase is related to the severity of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: Genetic determinants for atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Oxidation contributes to low glutathione in the airways of children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13510002.2016.1256119

Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome

21 January 2018

1 reference

12 December 2020

Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization

1 reference

12 December 2020

Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration

1 reference

12 December 2020

Neutrophils convert tyrosyl residues in albumin to chlorotyrosine

1 reference

12 December 2020

Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase

1 reference

12 December 2020

Characterization of the Asp94 and Glu242 mutants in myeloperoxidase, the residues linking the heme group via ester bonds

1 reference

12 December 2020

Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease

1 reference

12 December 2020

Coronary Bypass Surgery with Internal-Thoracic-Artery Grafts — Effects on Survival over a 15-Year Period

1 reference

12 December 2020

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes

1 reference

12 December 2020

Potential role of plasma myeloperoxidase level in predicting long-term outcome of acute myocardial infarction

1 reference

12 December 2020

Reaction of compound III of myeloperoxidase with ascorbic acid

1 reference

12 December 2020

Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease

1 reference

12 December 2020

Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion

1 reference

12 December 2020

High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase

1 reference

12 December 2020

The metabolism and dechlorination of chlorotyrosine in vivo

1 reference

12 December 2020

Kinetics and mechanisms of hypochlorous acid reactions

1 reference

12 December 2020

A kinetic study of the reaction between human myeloperoxidase, hydroperoxides and cyanide inhibition by chloride and thiocyanate

1 reference

12 December 2020

Biomarkers of neutrophil-mediated glutathione and protein oxidation in tracheal aspirates from preterm infants: association with bacterial infection

1 reference

12 December 2020

Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis

1 reference

12 December 2020

Thiocyanate is an efficient endogenous scavenger of the phagocytic killing agent hypobromous acid

1 reference

12 December 2020

Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina

1 reference

12 December 2020

Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima

1 reference

12 December 2020

A paramagnetic contrast agent with myeloperoxidase-sensing properties

1 reference

12 December 2020

Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome

1 reference

12 December 2020

Interaction of Acetaminophen with Myeloperoxidase Intermediates: Optimum Stimulation of Enzyme Activity

1 reference

12 December 2020

Ferrous iron-induced luminol chemiluminescence: a method for hydroxyl radical study

1 reference

12 December 2020

On the irreversible destruction of reduced nicotinamide nucleotides by hypohalous acids

1 reference

12 December 2020

Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing

1 reference

12 December 2020

Thiocyanate and chloride as competing substrates for myeloperoxidase.

1 reference

12 December 2020

Comparision of inflammatory biomarkers for detection of coronary stenosis in patients with stable coronary artery disease

1 reference

12 December 2020

The Met243 sulfonium ion linkage is responsible for the anomalous magnetic circular dichroism and optical spectral properties of myeloperoxidase

1 reference

12 December 2020

Redox properties of the couple compound I/native enzyme of myeloperoxidase and eosinophil peroxidase

1 reference

12 December 2020

Increased uptake of alpha-hydroxy aldehyde-modified low density lipoprotein by macrophage scavenger receptors

1 reference

12 December 2020

Metabolism of myeloperoxidase-derived 2-chlorohexadecanal

1 reference

12 December 2020

Outcome in medically treated coronary artery disease. Ischemic events: nonfatal infarction and death

1 reference

12 December 2020

Phagocytic activity and oxidative burst of granulocytes in persons with myeloperoxidase deficiency

1 reference

12 December 2020

Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids

1 reference

12 December 2020

Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease

1 reference

12 December 2020

10.1080/13510002.2016.1256119

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json

12 May 2020

PubMed publication ID

27884085

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837458&resulttype=core&format=json